Recursion· RecursionPharma·· 27 天前AI 评分36
Recursion入选State of AI报告
Thanks to @nathanbenaich and @airstreet for their annual State of AI Report. We’re happy to be included for our work on REC-4881, a MEK1/...
AI 导读
感谢@nathanbenaich和@airstreet发布年度《State of AI Report》。我们很高兴因REC-4881相关工作被收录，这是一种MEK1/2抑制剂，目前处于针对FAP的2期临床试验。同样被收录的还有Nesso-1：一个开源模型，可在数秒内预测结合亲和力，助力更快的早期药物发现。
来源：Recursion · x.com